Latest Developments in Global Jak2 Inhibitor Market

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Medical Devices Global Jak2 Inhibitor Market Latest Developments
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Jak2 Inhibitor Market

  • Medical Devices
  • Upcoming Report
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
Buy Now Buy Now

  • In September 2024, AbbVie expanded clinical trials for Upadacitinib (Rinvoq) to assess its efficacy in treating alopecia areata and ulcerative colitis
  • In October 2020, announced new data supporting the long-term efficacy and safety of its JAK2 inhibitor Abrocitinib for atopic dermatitis

Frequently Asked Questions

Browse Related Pages

Banner